David Baram: Founder and CEO of EmendoBio
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.